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Abstract
Background: Esophageal verrucous carcinoma is a rare variant of esophageal squamous cell carcinoma. In most cases,
verrucous carcinoma presents as an exophytic, slow-growing mass with an extensive superficial growth pattern.
Symptoms often include an insidious onset of dysphagia resulting in weight loss. In a patient presenting with super
early-stage verrucous carcinoma, we were able to eliminate the aberration using endoscopic submucosal dissection.
Case presentation: An asymptomatic 68-year-old Asian man was found to have an abnormality in his esophagus. The
abnormality was discovered, by chance, in a barium study for a health checkup. Esophagogastroduodenoscopy
revealed a 1-centimeter polypoid lesion covered with squamous epithelium. Biopsies showed squamous high-grade
intraepithelial neoplasia. An endoscopic submucosal dissection was performed and the histopathological findings
showed a well-differentiated squamous cell carcinoma with hyperkeratosis with a church spire configuration. These
features are consistent with the growth pattern of verrucous carcinoma.
Conclusions: Verrucous carcinoma can manifest as a small mass with nonclinical symptoms and endoscopic
submucosal dissection is useful as a curative treatment. We must consider that verrucous carcinoma can manifest as
appearance of a polyp that is not papillary or warty-like with and without extensive superficial growth appearance.
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Background
Esophageal verrucous carcinoma (VC) is a rare variant
of esophageal squamous cell carcinoma. In most cases, it
usually presents as an exophytic, slow-growing mass
emerging as papillary or warty-like, with an extensive
superficial growth pattern [1–6]. Diagnosis is often
delayed resulting in surgical treatment at an early stage
of VC [2–6]. Endoscopic submucosal dissection (ESD) is
an advanced endoscopic technique that allows for the
complete en bloc resection and possible cure of superfi-
cial gastrointestinal neoplasms [7–9]. We here report
that VC was identified in a small atypical VC and was
completely cured by an ESD.
Case presentation
By chance, an asymptomatic 68-year-old Asian man was
found to have an abnormality in his esophagus by bar-
ium study for mass screening. He was referred to our
hospital and underwent an esophagogastroduodeno-
scopy which showed a 1-centimeter polypoid appearance
covered with squamous epithelium in the distal esopha-
gus (Fig. 1). Biopsies showed squamous high-grade
intraepithelial neoplasia. An endoscopic submucosal dis-
section (ESD) was performed and the histopathological
findings showed a well-differentiated squamous cell car-
cinoma with hyperkeratosis with a church spire config-
uration (Fig. 2). These features were consistent with the
growth pattern of VC. No vessel invasion or lymphatic
permeation was recognized of this resected specimen.
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Discussion
Esophageal verrucous carcinoma (VC) is a rare variant
of esophageal squamous cell carcinoma. The majority of
the cases are associated with smoking, reflux esophagitis,
alcohol use, human papilloma virus (HPV), achalasia,
and other chronic inflammatory conditions. An inci-
dence rate of such cancer has been shown to be higher
in males than females, with a ratio of 2:1, and seen in
the age group from 35 to 80 years [1].
We ascertained two important clinical issues. VC can
manifest as a small mass without clinical symptoms and
ESD is useful as a curative treatment.
With regard to the first clinical issue, VC can manifest
as a small mass without clinical symptoms. VC of the
esophagus is a rare malignant epithelial tumor represent-
ing a variant of squamous cell carcinoma. VC was first
reported in 1967 [10]. Since then, 44 cases have been re-
ported in the literature. The endoscopic appearance of
VC usually presents with an exophytic, whitish, wart-like
mucosal surface, and is typically diagnosed months to
years after the onset of symptoms such as dysphagia
and weight loss [1–6]. Most esophagus squamous cell
carcinomas are not stained with a Lugol iodine due to the
fact they contain lesser amounts of glycogen. VC, how-
ever, has an increased amount of glycogen due to a slow
growth pattern. A PubMed MEDLINE search was per-
formed at the Jikei University Library of Medline using
the keywords “verrucous cancer” and “esophagus”. Forty-
four case reports were determined before October 19,
2015. In forty-three of the 44 cases (or 97.7 %) VC was
found to have the appearance of an exophytic, whitish and
wart-like mucosal surface, except for one report [11]. One
case reported VC with an atypical expression. Tajiri et al.
reported the endoscopic appearance as an elevated papil-
lary lesion, which was quite different from our findings.
We therefore assume that the incipience of VC has
various endoscopic forms.
Concerning the second clinical issue, we learned that
ESD is useful for curative treatment [10–12]. In the last
decade, ESD, a therapeutic endoscopic technique, has
been used to excise superficial GI neoplastic lesions.
ESD is an alternative, or replacement therapy, to endo-
scopic mucosal resection (EMR). An ESD is performed
using the following technique:
Fig. 1 a An endoscopic picture showing a polypoid lesion in the distal esophagus. b Endoscopic image stained by iodine. The lesion is within
the iodine-stained area
Fig. 2 a Photomicrograph of the resected esophageal specimen shows epithelial downgrowth and invasive findings (H&E, original magnification,
×20). b High-magnification image shows well-differentiated squamous cell carcinoma and focal hyperkeratosis with a church spire configuration
(H&E, original magnification, ×400). Black arrow and circle indicate a focal hyperkeratosis with a church spire configuration
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1. Circumferential markings are made a few millimeters
outside and around the margin of the lesion using
brief bursts of cautery with a Dual knife (KD-650L;
Olympus Medical Systems, Tokyo, Japan).
2. Next, submucosal injections are performed along the
perimeter of the markings to raise the lesion. A
solution of 0.5 % sodium hyaluronate (Mucoup;
Seikagaku Corporation, Tokyo, Japan) in 10 %
glycerine solution with 0.025 % epinephrine and 0.05 %
indigo carmine is used.
3. Third, an incision is made along the perimeter of the
markings. This isolates the injected area.
4. Lastly, using an endoscopic knife, the raised superficial
lesion is filleted away from the submucosa and
removed.
The case described above is the first known report
using ESD as a treatment for early-stage VC. Table 1
(below) shows the methods of treatment for VC since it
was first reported [10]. Twenty-six cases were surgically
treated and only one by EMR [11]. Because of the slow-
growing tumor character causing late-stage detection,
most cases are not candidates for noninvasive curative
treatments like EMR or ESD. Because we identified the
tumor in our patient to be VC in an early stage, we were
able to use ESD as a treatment. We reason that ESD will
decrease the local recurrence rate after endoscopic tissue
resection [12–14]. Our patient was thereby cured “en
bloc” using a minimally invasive dissection technique
instead of surgical resection.
Conclusions
VC can manifest as a small mass without clinical symp-
toms. ESD is a useful curative treatment in the removal
of VC. It is further understood that VC can manifest
with an atypical polyp appearance and not with its typ-
ical papillary or warty-like appearance. It is noteworthy
to consider that unknown expressions of VC exist, caus-
ing future undetected VC cases. ESD can be a curative
treatment if VC lesions are detected early with superfi-
cial growth. Subsequent reports should be collected and
analyzed to determine whether “hidden” VC cases might
be detected and diagnosed and whether ESD use may
contribute to curative treatment.
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